Outcomes of Treatment and Predictors of Response to Sofosbuvir plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection.
Infectious disorders drug targets(2020)
Abstract
Twelve weeks regimen of sofosbuvir plus simeprevir was considered to be safe and tolerable in treatment of HCV genotype 4; also it was associated with high SVR (97.6%).
MoreTranslated text
Key words
Genotype 4,HCV,simeprevir.,sofosbuvir
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined